Hospital
Mercy Hospital, INC
Mercy Hospital, INC was paid $2.56M by Medicaid between Jan 2018 and Dec 2018, across 102 billing codes. Its largest line is J3490, Unclassified drugs — 19% of everything it billed.
33Billing provider infoMERCY HOSPITAL, INC
CHARLOTTE, NC 28207
CHARLOTTE, NC 28207
33aNPI1497792550assigned 05/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.56M
24GClaims65,747
24DCodes billed102
24AFirst – last monthJan 2018 – Dec 2018
Compared with peers
Next to other General Acute Care Hospital providers in North Carolina
Rank by total paid#72 of 92
Median peer was paid$11.47M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 65,747 | $2.56M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J3490 | Unclassified drugs | 19% | 9,658 | 3,886 | $474K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 4,306 | 4,061 | $318K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.6% | 3,850 | 3,551 | $247K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.7% | 3,259 | 2,918 | $197K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 7.6% | 724 | 549 | $195K |
| 80053 | Comprehensive metabolic panel | 7.5% | 3,693 | 3,270 | $193K |
| J0690 | Injection, cefazolin sodium, 500 mg | 4.6% | 120 | 86 | $117K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 4.4% | 316 | 285 | $111K |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 2.3% | 562 | 503 | $59K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.3% | 1,126 | 938 | $58K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2.2% | 632 | 545 | $57K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2.0% | 332 | 309 | $52K |
90 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 464 | $48K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1.4% | 207 | $36K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 1,835 | $33K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1.3% | 350 | $33K |
| 87081 | 1.2% | 433 | $30K | |
| J8540 | Dexamethasone, oral, 0.25 mg | 1.1% | 262 | $28K |
| 81003 | 1.1% | 1,507 | $27K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 760 | $25K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 595 | $24K |
| 84702 | <1% | 255 | $19K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 168 | $18K |
| 81002 | <1% | 1,088 | $17K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 645 | $15K |
| S0028 | Injection, famotidine, 20 mg | <1% | 63 | $15K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 358 | $11K |
| 85027 | <1% | 2,577 | $9K | |
| G0378 | Hospital observation service, per hour | <1% | 392 | $9K |
| 87210 | <1% | 403 | $9K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 235 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 256 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,546 | $5K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 14 | $5K |
| 73562 | <1% | 43 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 451 | $4K |
| 76830 | Ultrasound, transvaginal | <1% | 201 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,847 | $3K |
| 81025 | <1% | 1,122 | $3K | |
| 73130 | <1% | 29 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,810 | $2K |
| 82962 | <1% | 425 | $2K | |
| 73610 | <1% | 21 | $2K | |
| 93971 | <1% | 45 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 209 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 28 | $2K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 160 | $2K |
| 73630 | <1% | 34 | $2K | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 69 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 462 | $2K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 61 | $2K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 511 | $1K |
| 87077 | <1% | 30 | $1K | |
| 73030 | <1% | 26 | $1K | |
| 84484 | <1% | 1,165 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 288 | $961.35 |
| 81015 | <1% | 94 | $680.71 | |
| 93975 | <1% | 226 | $669.79 | |
| 74018 | <1% | 12 | $561.38 | |
| 72100 | <1% | 44 | $553.41 | |
| 83690 | <1% | 1,270 | $537.83 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 439 | $502.50 |
| 83605 | <1% | 386 | $394.75 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 314 | $272.41 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 93 | $251.25 |
| 85610 | <1% | 224 | $245.08 | |
| 94760 | <1% | 230 | $228.55 | |
| 81000 | <1% | 56 | $146.15 | |
| 80320 | <1% | 51 | $142.41 | |
| 86901 | <1% | 112 | $141.13 | |
| 83735 | <1% | 838 | $119.97 | |
| 81001 | <1% | 45 | $116.87 | |
| 87040 | <1% | 137 | $113.72 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 230 | $68.72 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 556 | $68.43 |
| 82803 | <1% | 373 | $49.44 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 462 | $16.18 |
| 96376 | <1% | 488 | $6.92 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 734 | $5.06 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 403 | $3.35 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,198 | $2.99 |
| 85018 | 0% | 13 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 1,773 | $0.00 |
| 94761 | 0% | 218 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 293 | $0.00 |
| 85379 | 0% | 60 | $0.00 | |
| 71045 | Radiologic examination, chest; single view | 0% | 30 | $0.00 |
| 83880 | 0% | 388 | $0.00 | |
| 76801 | 0% | 62 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 13 | $0.00 |
| 59025 | Fetal non-stress test | 0% | 346 | $0.00 |
| 80061 | Lipid panel | 0% | 13 | $0.00 |
| 84439 | 0% | 50 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 1,178 | $0.00 |
| 80076 | 0% | 14 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 78 | $0.00 |
| 87186 | 0% | 60 | $0.00 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 32 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 17 | $0.00 |
| 90715 | 0% | 14 | $0.00 | |
| 86900 | 0% | 18 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOMBAR, GREG (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| The Charlotte-Mecklenburg Hospital Authority | Kings Mountain, NC | $3K |
| Carolinas Medical Center | Charlotte, NC | $2K |
| The Charlotte-Mecklenburg Hospital Authority | Monroe, NC | $1K |
| The Charlotte-Mecklenburg Hospital Authority | Albemarle, NC | $357.50 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.